Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: t36 who wrote (3889)	12/18/1997 3:07:00 PM
From: Anthony Ostroski	Read Replies (1) \| Respond to of 23519

Comments on this please!!!!!! "As a result, Asensio & Company found that a very significant portion of Vivus' Muse product sales were allegedly sold through outlets not monitored by IMS' NPA service. NPA is the recognized industry leader providing a complete and precise view of the prescription marketplace. Asensio & Company requested a description of Vivus customers not tracked by IMS' NPA audit or other information that could explain the discrepancy. Vivus failed to provide any of the requested information. Asensio & Company believes Vivus' 25% sales drop is a result of poor product performance" and early nonrecurring sales to undisclosed sources.